Equity
€1.0m ▲ 32.0%
Storms Pharma has made a profit in every financial year since 2018.
Storms Pharma
Lifetime
8 annual accounts with figures on one time axispeak €79,034 (2019)
€77,174▲ 24.3%
peak €268,223 (2019)
€249,362▲ 35.9%
peak €1.0m (2025)
€1.0m▲ 32.0%
€1.0m▼ 19.6%
Board1 name since 2017
1 directorSTORMS Valerie Angèle Florimond
Documentsfilings and deeds
03-07-202628 days before the deadline
2025abbreviated format
Gross margin from €62,102 to €77,174Result from €183,555 to €249,362Equity from €778,197 to €1.0mDebts from €1.2m to €1.0mCash from €24,582 to €14,370
Key points
from the 2025 annual accountsResult
€249,362 ▲ 35.9%
The result rose in 2025 from €183,555 to €249,362.
Filings
8 annual accounts 1 late
The 2019 accounts came 31 days late. The other seven were filed on time.
Financial institution: outside the modelBankruptcy probability: sector outside the model
Checked score
Outside the general model
Model not applicable to financial institutions
The Checked score measures liquidity, leverage and margins against the norms for trading and manufacturing companies. A bank, insurer or financial holding has a very different balance sheet. Those ratios and the score mean nothing here. So there is no financial strength either.
Bankruptcy probability within 12 months
The company is a financial institution: a bank, insurer or financial holding. Its balance sheet works differently from that of a trading or manufacturing company. A bankruptcy probability from the general model would mislead here.
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
1 signal, which does not raise the risk
1 signal.
neutral
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 03-07-2026, 28 days ahead of the deadline.
NBB · 8 filingsDeviation from the deadline
2025
28 days early
2024
30 days early
2023
20 days early
2022
25 days early
2021
6 days early
2020
15 days early
2019
31 days late
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
The company filed its last 7 accounts on average 13 days before the deadline. In the sector (NACE 64), the median for financial year 2024 was 14 days before the deadline, and 28% of those companies filed late.
Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 6 July (5 of the last 5 accounts filed within 30 days either side of that date).
Companies Code · seven monthsWhere today falls in the filing period
11-11-2026 today31-12-2026 year end31-07-2027 deadline
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0683469918
Change of role: STORMS Valerie Angèle Florimond, from manager to director
Gazette deed
Incorporation
Founders: STORMS Valerie Angèle Florimond and RABAEY Jonas Willy · Founding capital of €100,000, 1,000 shares · Appointment: STORMS Valerie Angèle Florimond (manager) · published on 20-10-2017 · Gazette deed
First establishment
Leo Kempenaersstraat 7, Heist-op-den-Berg
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| Storms Pharma Heist-op-den-Berg | €2.0m | €77,174 | 50.6% | - |
| DIGIGOS Mortsel | €2.1m | €75,079 | 97.9% | - |
| PLUG-IN MOBILITY Herentals | €2.2m | €66,147 | 93.2% | - |
| DIEGO DE WOLF RAMEN EN DEUREN Heist-op-den-Berg | €2.5m | €87,452 | 10.1% | - |
| ZENDIEL Antwerp | €1.6m | €88,074 | 30.5% | - |
| EAST WALK Lasne | €2.0m | €70,719 | 29.1% | - |
| ROTSAERT EPF Zedelgem | €2.0m | €77,580 | 28.8% | - |
These companies have the same main activity as Storms Pharma: activities of holding companies (NACE 64210). They are comparable in size and age: total assets between €1.6m and €2.5m, founded between 2016 and 2018.
Official details
Source: KBO- Status
- Active since 18-10-2017Normal situation
- Activity
- Activities of holding companiesNACE 64210
- Establishment unit
- 2.270.423.5702223 Heist-op-den-Berg, since 18-10-2017
- Financial year end
- 31 December
- Peppol
- Reachable since 24-11-2023
Annual accounts 2025
- €2.0m▲ 0.2%
- Filing
- Filed on 03-07-2026, 28 days before the end of the filing period
Insights on Storms Pharma
Storms Pharma files the abbreviated format. That format states no turnover. The gross margin rose from €38,962 in 2018 to €77,174 in 2025.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about Storms Pharma
- What is the company number of Storms Pharma?
- The company number of Storms Pharma is 0683.469.918. The VAT number is the same number with BE in front: BE 0683.469.918.
- Where is Storms Pharma based?
- The registered office is at Leo Kempenaersstraat 7, 2223 Heist-op-den-Berg.Company details
- What does Storms Pharma do?
- According to the KBO register, the main activity is activities of holding companies (NACE 64210).
- What is the legal form of Storms Pharma?
- Storms Pharma is a private limited company (BV).
- When was Storms Pharma founded?
- Storms Pharma was founded on 18-10-2017.
- Is Storms Pharma still active?
- Yes, Storms Pharma is an active enterprise in the KBO register.
- What is the turnover of Storms Pharma?
- The turnover in financial year 2025 is ≈ €180,000. This figure is estimated from the gross margin of €77,174 and 40 comparable companies (NACE 64210). It probably lies between €120,000 and €220,000.Financials
- Is Storms Pharma profitable?
- In financial year 2025, Storms Pharma made a profit of €249,362.
- Where can I find the annual accounts of Storms Pharma?
- Storms Pharma filed 8 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of Storms Pharma due?
- Storms Pharma must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check See what changed in the latest annual accounts.What changed See this company's board, registered office and name on a given date.Company as of a date
See how customers, suppliers and banks see your own company and what to improve first.